Mitochondrial DNA Content (qPCR) Analysis - Liver

Casandra

Casandra Test Code BA67943Version 1 (DRAFT)

Performing Lab

Lab Baylor GeneticsLab Test ID 3720CPT Code 81479

Mitochondrial DNA Content (qPCR) Analysis - Liver

Clinical Use

Use

The Mitochondrial DNA (mtDNA) Content Quantification - Liver is crucial in assessing mtDNA depletion in hepatic cells. This measurement aids in determining causative nuclear genes for sequencing analysis, particularly in individuals suspected of having mitochondrial DNA depletion syndromes (MDS). These disorders are marked by a significant reduction of mtDNA, leading to various clinical manifestations such as hypotonia, lactic acidemia, and hepatopathy. Identifying mtDNA depletion is imperative for accurate diagnosis and informed clinical decisions regarding further genetic testing and management, as variations in specific nuclear genes can contribute to the spectrum of mitochondrial disease. Thus, understanding the mtDNA level in liver tissues not only provides insights into the individual's metabolic state but also helps in guiding therapeutic approaches and genetic counseling for families at risk.

Special Instructions

Testing is recommended for individuals showing symptoms indicative of mtDNA depletion syndromes. Flash freezing and rapid shipping are critical to maintain sample integrity for accurate results. The sample should be taken under specific conditions—using low temperatures to ensure preservation of mitochondrial DNA content for reliable analysis. Providers might want to coordinate with transport services to ensure adherence to these requirements and maintain specimen viability during transit.

Limitations

Results may be influenced by inadequate sample quality or improper handling during collection and shipping. Extreme care must be taken to preserve the integrity of liver samples by utilizing flash freezing techniques immediately post-collection. The presence of other factors in the patient's clinical history might complicate the interpretation of mtDNA levels. This analysis does not directly identify specific pathogenic variants within nuclear genes but serves as a preliminary assessment that may warrant further, more detailed genetic testing to confirm diagnoses of mitochondrial diseases. Further studies may be necessary in certain cases to correlate mtDNA content with clinical symptoms, and it is vital to educate patients about the importance of follow-up consultations to understand their results better.

Test Details